Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By

Showing results 161 - 170 of 198

Selected Filters:
17 April 2019

Health care providers’ knowledge, attitudes, and practices (KAP) relevant to oral PrEP service provision to AGYW in Zimbabwe Preliminary Qualitative Findings

This study of knowledge, attitudes and practices (KAP) among health care providers in Zimbabwe explores questions about PrEP services for adolescent girls and young women. The findings offer insights that can be applied to provider training and support.

Research, Service Delivery

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Tanzania Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Tanzania was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Malawi Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Malawi was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Zimbabwe Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Zimbabwe was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Kenya Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Kenya was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Uganda Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Uganda was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Rwanda Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Rwanda was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Seven Country Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Rwanda, Uganda, Kenya, Zimbabwe, Malawi, Tanzania and South Africa were prioritized for analysis due to the state of the HIV epidemic in…

Research

Document
2 April 2019

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection — Second edition

In June 2016, WHO released guidelines on the diagnosis of HIV infection, the use of ARVs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral…

Monitoring & Evaluation, Normative Guidance/Policies, Research

External Link
2 April 2019

Oral PrEP Risk Assessment Tools at a Glance

To understand the relative strengths and weaknesses of current risk assessment tools and approaches being used to help guide implementation, an analysis of such tools was conducted to investigate how risk assessment tools (www.prepwatch.org/risk-assessment-tools) are used, how well tools identify those at risk for HIV infection and how best implementers can use these tools to…

Demand Creation/Marketing, Research, Normative Guidance/Policies

Document